Ossifying fibromyxoid tumor of soft parts--a clinicopathologic and immunohistochemical study of 104 cases with long-term follow-up and a critical review of the literature
- PMID: 18469710
- DOI: 10.1097/PAS.0b013e318160736a
Ossifying fibromyxoid tumor of soft parts--a clinicopathologic and immunohistochemical study of 104 cases with long-term follow-up and a critical review of the literature
Abstract
Ossifying fibromyxoid tumor (OFT) is a unique soft tissue tumor of uncertain histogenesis. The majority of reported cases (approximately 220) have pursued a benign clinical course. However, recent literature has emphasized the existence of morphologically atypical and clinically malignant examples of this tumor and proposed guidelines for assessment of biologic potential. In the present study, we evaluated 104 cases of OFT from the Armed Forces Institute of Pathology, accessioned between the years 1970 and 2007. Herein, OFT was strictly defined as a tumor with lobular architecture, predominantly epithelioid cell morphology, a low level of atypia, corded and trabecular growth patterns, moderate amounts of myxocollagenous matrix, and often, focal peripheral metaplastic bone formation. Tumors that lacked conventional morphology were excluded. The exclusion group included cutaneous mixed tumors, low-grade fibromyxoid sarcomas, and extraskeletal osteosarcomas. The OFTs occurred in 64 men and 40 women with a median age of 50 years (range, 21 to 81 y). The tumor size ranged from 0.7 to 17 cm (median, 3 cm). The mitotic rate varied from 0 to 41 mitotic figures per 50 HPFs (median, 2/50 HPFs). Tumor cell nuclei typically contained small, distinct nucleoli, and necrosis was infrequent (11/104). The great majority of tumors (67/71, 94%) were positive for S100 protein, whereas only occasional examples had (focal) positivity for desmin, glial fibrillary acidic protein, and an AE1/AE3 keratin cocktail. Local recurrences were documented in 9 of 41(22%) living patients, usually 10 or more years after primary surgery, but there were no metastases. A mitotic rate of >2 mitotic figures/50 HPFs was a risk factor for local recurrence, but necrosis, tumor size, the presence of satellite nodules, and positive margins were not. When OFT is strictly defined by the criteria noted above, there is potential for local recurrence, but there seems to be little or no risk for metastasis.
Similar articles
-
Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy.Am J Surg Pathol. 2010 May;34(5):715-22. doi: 10.1097/PAS.0b013e3181d90370. Am J Surg Pathol. 2010. PMID: 20410812
-
Neurothekeoma: an analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information.Am J Surg Pathol. 2007 Jul;31(7):1103-14. doi: 10.1097/PAS.0b013e31802d96af. Am J Surg Pathol. 2007. PMID: 17592278
-
Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior.Am J Surg Pathol. 2011 Feb;35(2):190-201. doi: 10.1097/PAS.0b013e3181ff0901. Am J Surg Pathol. 2011. PMID: 21263239
-
Ossifying fibromyxoid tumor of soft parts: a clinicopathologic study of 70 cases with emphasis on atypical and malignant variants.Am J Surg Pathol. 2003 Apr;27(4):421-31. doi: 10.1097/00000478-200304000-00001. Am J Surg Pathol. 2003. PMID: 12657926 Review.
-
Ossifying fibromyxoid tumor in the mandibular gingiva: case report and review of the literature.J Periodontol. 2009 Apr;80(4):687-92. doi: 10.1902/jop.2009.080535. J Periodontol. 2009. PMID: 19335090 Review.
Cited by
-
Response to isolated limb perfusion and chemotherapy with epirubicin plus ifosfamide in a metastatic malignant ossifying fibromyxoid tumor.Clin Sarcoma Res. 2017 Dec 28;7:20. doi: 10.1186/s13569-017-0086-2. eCollection 2017. Clin Sarcoma Res. 2017. PMID: 29299229 Free PMC article.
-
A rare case report of a typical variant ossifying fibromyxoid tumor (OFMT), located in the retroauricular perimastoid region.Int J Surg Case Rep. 2018;44:16-19. doi: 10.1016/j.ijscr.2018.02.017. Epub 2018 Feb 14. Int J Surg Case Rep. 2018. PMID: 29462752 Free PMC article.
-
Ossifying fibromyxoid tumor: a rare case involving the paraspinal musculature and spinous processes.Skeletal Radiol. 2025 Aug 15. doi: 10.1007/s00256-025-05012-2. Online ahead of print. Skeletal Radiol. 2025. PMID: 40813495
-
Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1.Genes Chromosomes Cancer. 2017 Jan;56(1):42-50. doi: 10.1002/gcc.22400. Epub 2016 Aug 26. Genes Chromosomes Cancer. 2017. PMID: 27537276 Free PMC article.
-
Myoepithelioma within the carpal tunnel: a case report and review of the literature.Int Semin Surg Oncol. 2009 Sep 9;6:15. doi: 10.1186/1477-7800-6-15. Int Semin Surg Oncol. 2009. PMID: 19740441 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous